Resultados de la búsqueda 91-100 of 4927 for Two-phase
Randomized Phase II/III Trial of Adjuvant ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer.
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...
The purpose of this study is to optimize profile questionnaire and matching algorithm developed in Phase ... two future steps: NSITE: Novel Strategies to Increase ...
... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity. Numeración de páginas Estudios clínicos. AnteriorPágina anterior · Ir a ...
This randomized phase II trial studies how well olaparib, cediranib ... Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients.
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...
The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 ... stage glioma tumors and evaluate response to therapy.
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Patients will be randomized 1:1 into the two arms. Patients randomized to ... Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?